Found 60 matching trials
Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2
PHASE2In previous studies, investigators have studied if a pre-meal insulin bolus...
Location
Institut de recherches cliniques de Montréal
Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D
NAA randomized controlled trial of Control-IQ, assessing glycemic control (ti...
Location
University of Virginia Center for Diabetes Technology
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
PHASE4BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Location
Unit of Endocrinology and Metabolic Diseases
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
NAIn this prospective, randomized, open-label, parallel group trial, the safe...
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward
NAAt least 20% of patients hospitalized in the general medical and surgical w...
Location
Assaf Harofe Medical Center
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
PHASE3This is a single center, prospective, randomized, double blinded placebo co...
Location
ECMC Ambulatory Center, 3rd Floor
Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation
PHASE2In previous studies, investigators have studied if a pre-meal insulin bolus...
Location
Institut de recherches cliniques de Montréal
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes
PHASE2Closed-loop strategy is composed of three components: glucose sensor to rea...
Location
Multiple Locations
Afrezza® INHALE-1 Study in Pediatrics
PHASE3INHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the...
Location
Children's Hospital Los Angeles
Post-exercise Insulin Reductions in Type 1 Diabetes
NAThe investigators hypothesise that reducing rapid-acting insulin dose after...
Location
Clinical Research Facility